DK200000691A - Pyrrolderivater - Google Patents
Pyrrolderivater Download PDFInfo
- Publication number
- DK200000691A DK200000691A DK200000691A DKPA200000691A DK200000691A DK 200000691 A DK200000691 A DK 200000691A DK 200000691 A DK200000691 A DK 200000691A DK PA200000691 A DKPA200000691 A DK PA200000691A DK 200000691 A DK200000691 A DK 200000691A
- Authority
- DK
- Denmark
- Prior art keywords
- formula
- compound
- xii
- lower alkyl
- carbon atoms
- Prior art date
Links
- 0 C[C@@](CC1*)[n]2c1ccc2*[Al] Chemical compound C[C@@](CC1*)[n]2c1ccc2*[Al] 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Description
hvor R er lavere alkyl med 1-6 carbonatomer, og X er halogen, cycliseres med en lithiumhindret amin i et aprot opløsningsmiddel til dannelse af en diester med formlen (XII):
(XII) (b) en divalent ester med formlen (XII) opnået i trin (a) forsæbes til dannelse af den tilsvarende divalente syre med formlen (XII):
(XM) hvor R er hydrogen, (c) den divalente syre med formlen (XII) opnået i trin (b) forestres til dannelse afen forbindelse med formlen (XVIII):
(XVIII) hvor R-gruppen i 1 -stillingen er lavere alkyl med 1-6 carbonatomer, (d) en forbindelse med formlen (XVIII) opnået i trin (c) decarboxyleres til dannelse af en forbindelse med formlen (XIX):
(XIX) hvor R har den ovenfor anførte betydning; (e) en forbindelse med formlen (XIX) opnået i trin (d) aroyleres med en amid elleret morpholid til dannelse af en forbindelse med formlen (I), hvor Ar er substitueret eller usubstitueret phenyl, 2- eller 3-furyl, 2- eller 3-thienyl eller 2- eller 3-pyrryl, som, når den er substitueret, kan have en eller flere lavere alkyl-, lavere alkoxy- eller halogengrupper i en hvilken som helst stilling, der er til rådighed, på ringen, og R er hydrogen eller lavere alkyl med 1-6 carbonatomer, og eventuelt (f) en forbindelse med formlen (I) omdannes til et farmaceutisk acceptabelt salt deraf.
PATENTKRAV 1. Fremgangsmåde til fremstilling af en forbindelse med den generelle formel (I):
(0 hvor
Ar er substitueret eller usubstitueret phenyl, 2- eller 3-furyl, 2- eller 3-thienyl eller 2- eller 3-pyrryl, som, når den er substitueret, kan have en eller flere lavere alkyl-, lavere alkoxy- eller halogengrupper i en hvilken som helst stilling, der er til rådighed, på ringen, og R er hydrogen eller lavere alkyl med 1-6 carbonatomer, elleret farmaceutisk acceptabelt salt af denne, kendetegnet ved, at (a) en forbindelse med formlen (XVI):
(XVI) hvor R er lavere alkyl med 1-6 carbonatomer, og X er halogen, cycliseres med en lithiumhindret amin i et aprot opløsningsmiddel til dannelse afen diester med formlen (XII):
(XII) (b) en divalent ester med formlen (XII) opnået i trin (a) forsæbes til dannelse af den tilsvarende divalente syre med formlen (XII):
(XII) hvor R er hydrogen, (c) den divalente syre med formlen (XII) opnået i trin (b) forestres til dannelse af en forbindelse med formlen (XVIII):
(XVIII) hvor R-gruppen i 1-stillingen er lavere alkyl med 1-6 carbonatomer, (d) en forbindelse med formlen (XVIII) opnået i trin (c) decarboxyleres til dannelse af en forbindelse med formlen (XIX);
(XIX) hvor R har den ovenfor anførte betydning; (e) en forbindelse med formlen (XIX) opnået i trin (d) aroyleres med en amid eller et morpholid til dannelse af en forbindelse med formlen (I), hvor Ar er substitueret eller usubstitueret phenyl, 2- eller 3-furyl, 2- eller 3-thienyl eller 2- eller 3-pyrryl, som, når den er substitueret, kan have en eller flere lavere alkyl-, lavere alkoxy- eller halogengrupper i en hvilken som helst stilling, der er til rådighed, på ringen, og R er hydrogen eller lavere alkyl med 1-6 carbonatomer, og eventuelt (f) en forbindelse med formlen (I) omdannes til et farmaceutisk acceptabelt salt deraf. 2. Fremgangsmåde ifølge krav 1, kendetegnet ved, at (a) en forbindelse med formlen (I) omdannes til den tilsvarende frie forbindelse med formlen (I), eller (b) en forbindelse med formlen (I) esterificeres, eller (c) en ester med formlen (I) omdannes til den tilsvarende frie forbindelse med formlen (l). 3. Fremgangsmåde ifølge krav 1 eller 2, hvor den dannede forbindelse er 5- benzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrol-1-carboxylsyre eller et farmaceutisk acceptabelt salt af denne. 4. Fremgangsmåde ifølge krav 1 eller 2, hvor den dannede forbindelse er 5-p- anisoyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrol-1-carboxylsyre eller et farmaceutisk acceptabelt salt af denne.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US316287 | 1987-01-14 | ||
| US07/003,104 US4849526A (en) | 1987-01-14 | 1987-01-14 | Process for preparing (±)-2,3-dihydro-1H-pyrrolo[1,2-A]pyrrole-1,7-dicarboxylates |
| US310487 | 1987-01-14 | ||
| US07/003,162 US4835288A (en) | 1987-01-14 | 1987-01-14 | Process for preparing (+)-2,3-dihydro-1H-pyrrolo[1,2-a]pyrrole-1,7-dicarboxylates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK200000691A true DK200000691A (da) | 2000-04-27 |
| DK175516B1 DK175516B1 (da) | 2004-11-15 |
Family
ID=26671322
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK198800143A DK174999B1 (da) | 1987-01-14 | 1988-01-13 | Pyrrolderivater |
| DK200000691A DK175516B1 (da) | 1987-01-14 | 2000-04-27 | Fremgangsmåde til fremstilling af pyrrolderivater |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK198800143A DK174999B1 (da) | 1987-01-14 | 1988-01-13 | Pyrrolderivater |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0275092B1 (da) |
| JP (1) | JP2665342B2 (da) |
| KR (1) | KR960001475B1 (da) |
| AU (1) | AU613334B2 (da) |
| CA (1) | CA1340404C (da) |
| DE (1) | DE3871533T2 (da) |
| DK (2) | DK174999B1 (da) |
| ES (1) | ES2041703T3 (da) |
| FI (1) | FI90344C (da) |
| GR (1) | GR3004788T3 (da) |
| HK (1) | HK39097A (da) |
| HU (8) | HU198927B (da) |
| IE (1) | IE62987B1 (da) |
| IL (1) | IL85094A (da) |
| NO (1) | NO169124C (da) |
| NZ (1) | NZ223175A (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0140134B1 (ko) * | 1994-11-16 | 1998-06-01 | 강재헌 | 피롤리진 유도체의 제조방법 |
| CN112898307A (zh) * | 2021-02-07 | 2021-06-04 | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | 一种酮咯酸杂质c及其制备方法与应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS539789A (en) * | 1976-07-14 | 1978-01-28 | Syntex Inc | Production of 55*22floyl** * 55*22thenoyl** * 55*33 floyl** and 55*33thenoyl** 1*22dihydroo3hhpyroro * 1*22a*pyrolee11carboxylic acid derivative |
| US4089969A (en) * | 1976-07-14 | 1978-05-16 | Syntex (U.S.A.) Inc. | 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof |
| US4097579A (en) * | 1977-03-31 | 1978-06-27 | Syntex (U.S.A.) Inc. | 5-(2-Pyrroyl)-1,2-dihydro-3H-pyrrolo 1,2-a!pyrrole-1-carboxylic acid derivatives and process for the production thereof |
| US4344943A (en) * | 1980-06-09 | 1982-08-17 | Syntex (U.S.A.) Inc. | 6-Chloro- or 6-bromo-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-1-carboxylic acids and derivatives thereof |
| US4353829A (en) * | 1980-11-21 | 1982-10-12 | Syntex (U.S.A.) Inc. | Process for 5-aroylation of 1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic esters |
| US4560699A (en) * | 1983-01-17 | 1985-12-24 | Syntex (U.S.A.) Inc. | 5-(4-Vinylbenzoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]-pyrrole-1-carboxylic acids and derivatives thereof and use as analgesics and anti-inflammatories |
-
1987
- 1987-12-14 HU HU875631A patent/HU198927B/hu not_active IP Right Cessation
-
1988
- 1988-01-13 HU HU88117A patent/HU200606B/hu unknown
- 1988-01-13 ES ES198888100390T patent/ES2041703T3/es not_active Expired - Lifetime
- 1988-01-13 IE IE8388A patent/IE62987B1/en not_active IP Right Cessation
- 1988-01-13 KR KR1019880000169A patent/KR960001475B1/ko not_active IP Right Cessation
- 1988-01-13 HU HU895354A patent/HU201728B/hu unknown
- 1988-01-13 DK DK198800143A patent/DK174999B1/da not_active IP Right Cessation
- 1988-01-13 EP EP88100390A patent/EP0275092B1/en not_active Expired - Lifetime
- 1988-01-13 HU HU895356A patent/HU203721B/hu unknown
- 1988-01-13 IL IL85094A patent/IL85094A/xx not_active IP Right Cessation
- 1988-01-13 AU AU10240/88A patent/AU613334B2/en not_active Expired
- 1988-01-13 DE DE8888100390T patent/DE3871533T2/de not_active Expired - Lifetime
- 1988-01-13 CA CA000556465A patent/CA1340404C/en not_active Expired - Lifetime
- 1988-01-13 FI FI880133A patent/FI90344C/fi not_active IP Right Cessation
- 1988-01-13 NO NO880127A patent/NO169124C/no not_active IP Right Cessation
- 1988-01-13 JP JP63006757A patent/JP2665342B2/ja not_active Expired - Lifetime
- 1988-01-13 HU HU895355A patent/HU203532B/hu unknown
- 1988-01-13 HU HU895355A patent/HUT52045A/hu unknown
- 1988-01-13 HU HU895356A patent/HUT52046A/hu unknown
- 1988-01-13 HU HU895354A patent/HUT51595A/hu unknown
- 1988-01-13 NZ NZ223175A patent/NZ223175A/xx unknown
-
1992
- 1992-06-04 GR GR920400600T patent/GR3004788T3/el unknown
-
1997
- 1997-03-27 HK HK39097A patent/HK39097A/xx not_active IP Right Cessation
-
2000
- 2000-04-27 DK DK200000691A patent/DK175516B1/da not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE780605L (en) | 1, 2-DIHYDRO-3H-PYRROLO [1,2-a] PYRROLES | |
| DE69022943D1 (de) | Verfahren zur Herstellung von Phenylessigsäurederivaten aus Thienopyridin und Zwischenprodukte von alpha-Bromphenylessigsäuren. | |
| DK161966C (da) | Fremgangsmaade til fremstilling af 5-aroylerede 1,2-dihydro-3h-pyrrolooe1,2-aaapyrrol-1-carboxylsyrer eller estere eller farmaceutisk acceptable salte deraf | |
| YU43235B (en) | Process for preparing 6-chloro-or 6-bromo-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-carboxylic acid and alkyl esthers thereoff | |
| DK200000691A (da) | Pyrrolderivater | |
| NO842152L (no) | Fremgangsmaate til fremstilling av maursyre | |
| FUJII et al. | Decarboxylation reactions. II. Reaction of conjugated unsaturated ketones and nitriles with carboxylic acids | |
| SE8105338L (sv) | Nytt sett att framstella apovinkaminsyraestrar | |
| JPS5718651A (en) | Preparation of phenylglycine derivative | |
| SE7905060L (sv) | Nya 1-pyrrol- och 1-pyrrolidin-karboxylsyraderivat och sett for framstellning derav | |
| RU94004974A (ru) | Способ получения натриевой соли 1-амино-1-цианамидо-2,2-дицианоэтилена | |
| YU46919B (sh) | Postupak za dobijanje derivata l-alanil-l-prolina | |
| SE8107683L (sv) | Xantinderivat | |
| ES8301243A1 (es) | Procedimiento de obtencion de acidos (3,2-c)-pirazol-11-oxo-olean-2,12-dien-18b-30-oico esterificados. | |
| DE69628516D1 (de) | Verfahren zur herstellung von 2-isocephem-derivaten | |
| JPS5461191A (en) | Preparation of 7beta-amino-3-methyl-3-cephem-4-carboxylic acids | |
| JPS5223093A (en) | Preparation of pyrrolo(1,2-c)pyrimidine derivatives | |
| GB974988A (en) | Process for the preparation of alpha, beta-unsaturated phosphonic acid esters | |
| KR790000325B1 (en) | Process of manufacturing adducts iof benzimidazolecarbmaic acid esters and organic sulfonic and sulfuric acids | |
| JPS5384901A (en) | Dimerization of n-acyl-alpha-amino acid ester | |
| TH5420EX (th) | ไธโอโนฟอสโฟนิคแอซีดเอสเทอร์ | |
| JPS5511502A (en) | Preparation of condensed heterocyclic compound | |
| SU1043991A1 (ru) | Способ получения алкиловых эфиров 4,5-дибром-2-гексеновой кислоты | |
| EP0117876A4 (en) | SULPHONIC ESTER DERIVATIVES AND THEIR PREPARATION PROCESS. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUP | Patent expired |